LATEST NEWS

Terumo Blood and Cell Technologies collaborates with MCQ to enable automated gas mixing for expansion of cell and gene therapies

Bark and Brew 5K Fun Run and Walk For a Cure

Terumo Blood and Cell Technologies’ Reveos® Automated Whole Blood Processing System Cleared by FDA for U.S. Commercial Use

Terumo Blood and Cell Technologies Appoints Veerle d'Haenens as General Manager, Cell Therapy Technologies.

Terumo Blood and Cell Technologies Presents First Quantum Flex Data for Multiple Size Bioreactors Showing Rapid T-Cell Expansion to Numbers Equivalent to a Therapeutic Dose

IMUGARD^® WB Platelet Pooling Set cleared by FDA, officially launched.

Donation to Blood Emergency Readiness Corps Supports an Adequate U.S. Blood Supply

Terumo Blood and Cell Technologies launches Quantum Flex bioreactor platform, one of the first systems that enables cell therapy commercialization from process development through manufacturing

Rika Plasma Donation System Reaches Critical Milestone with Plasma Collection from First Donor

Collaboration with Eliaz Therapeutics in the development of a novel therapeutic apheresis treatment for acute kidney injury (AKI)